Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-10 9:45 pm Purchase | 2025-11-04 | 13G | 1-800-FLOWERS.COM, Inc. FLWS | Newtyn Management, LLC | 2,959,375 8.100% | 442,909 (+17.60%) | Filing History |
| 2025-11-10 9:29 pm Purchase | 2025-09-30 | 13G | 1-800-FLOWERS.COM, Inc. FLWS | Newtyn Management, LLC | 2,516,466 6.900% | 2,516,466 (New Position) | Filing History |
| 2025-08-14 4:05 pm Purchase | 2025-06-30 | 13G | USA Rare Earth Inc USAR | Newtyn Management, LLC | 444,353 0.500% | 444,353 (New Position) | Filing History |
| 2025-08-14 4:05 pm Purchase | 2025-06-30 | 13G | Magnera Corp. MAGN | Newtyn Management, LLC | 2,271,500 6.400% | 2,271,500 (New Position) | Filing History |
| 2025-05-15 5:25 pm Purchase | 2025-03-31 | 13G | Cannae Holdings, Inc. CNNE | Newtyn Management, LLC | 4,600,000 7.300% | 4,600,000 (New Position) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-12-31 | 13G | Theravance Biopharma, Inc. TBPH | Newtyn Management, LLC | 4,757,403 9.700% | 657,403 (+16.03%) | Filing History |
| 2025-02-14 4:05 pm Sale | 2024-12-31 | 13G | BV Financial, Inc. BVFL | Newtyn Management, LLC | 0 0.000% | -682,980 (Position Closed) | Filing History |
| 2025-01-07 5:20 pm Purchase | 2024-11-18 | 13G | Inflection Point Acquisition Corp. II IPXX | Newtyn Management, LLC | 700,000 8.300% | 700,000 (New Position) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | City Office REIT, Inc. CIO | Newtyn Management, LLC | 3,938,000 9.800% | 734,758 (+22.94%) | Filing History |
| 2024-11-14 4:05 pm Unchanged | 2024-09-30 | 13G | Tectonic Therapeutic, Inc. TECX | Newtyn Management, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | Franklin Street Properties Corp. FSP | Newtyn Management, LLC | 7,150,000 6.900% | 7,150,000 (New Position) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | BV Financial, Inc. BVFL | Newtyn Management, LLC | 682,980 5.800% | -317,020 (-31.70%) | Filing History |
| 2024-08-16 4:05 pm Purchase | 2024-08-07 | 13G | Theravance Biopharma, Inc. TBPH | Newtyn Management, LLC | 4,100,000 8.400% | 4,100,000 (New Position) | Filing History |
| 2024-03-08 4:05 pm Purchase | 2024-02-28 | 13G | Veradigm Inc. MDRX | Newtyn Management, LLC | 10,500,000 9.600% | 10,500,000 (New Position) | Filing History |
| 2024-03-07 6:00 pm Sale | 2024-03-05 | 13D | Sensei Biotherapeutics, Inc. SNSE | Newtyn Management, LLC | 62,112 4.950% | -10,721 (-14.72%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | AVROBIO, Inc. AVRO | Newtyn Management, LLC | 227,848 6.100% | 227,848 (New Position) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT | Newtyn Management, LLC | 3,021,500 8.400% | 3,021,500 (New Position) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | City Office REIT, Inc. CIO | Newtyn Management, LLC | 3,203,242 8.000% | 3,203,242 (New Position) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | BV Financial, Inc. BVFL | Newtyn Management, LLC | 1,000,000 8.800% | 1,000,000 (New Position) | Filing History |
| 2024-02-14 4:05 pm Sale | 2023-12-31 | 13G | PACIFIC GAS & ELEC CO 6 PR PCGPRA | Newtyn Management, LLC | 0 0.000% | -665,610 (Position Closed) | Filing History |